NVTA News and Press, Invitae Corporation From 09/22/23

Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard PR Newswire SAN FRANCISCO , Sept. 22, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it received a noti...

2023-09-21 05:00:00 ET Fool.com contributor Parkev Tatevosian considers Invitae (NYSE: NVTA) stock and its financial prospects to determine if investors should buy the stock. *Stock prices used were the afternoon prices of Sept. 18, 2023. The video was published on Sept. 20, 2...

2023-09-19 05:30:00 ET It's best not to go all in on high-risk stocks, but that doesn't mean you should avoid them entirely. If you can tolerate some risk, certain players could make a good addition to a diversified portfolio. That's because, along with the risk, these companies also of...

2023-09-14 14:00:00 ET Since December 2021, superstar investor Cathie Wood has been adding to her position in genetic-testing company Invitae (NYSE: NVTA) while many investors were doing just the opposite. The stock has declined more than 90% since that time. Wood's latest Invitae t...

Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer PR Newswire – Invitae adds chief commercial officer to leadership team; Innovative leader to help expand market share and drive revenue growth – SAN FRANCISCO , Aug. 28 , 20...

2023-08-24 10:00:34 ET Gainers: CollPlant Biotechnologies ( CLGN ) +11% NeuBase Therapeutics ( NBSE ) +7% NeuroPace ( NPCE ) +7% Bionomics ( BNOX ) +6% Enhabit ( EHAB ) +16% Losers: NanoVibronix ( NAOV ) -15% ...

Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer PR Newswire – Research published in European Urology Oncology shows restrictive genetic testing criteria miss a significant number of prostate cancer patients with potentially actionable i...

2023-08-14 17:06:08 ET More on Invitae Invitae: Revenue Troubles Build Invitae Corporation ( NVTA ) Q2 2023 Earnings Call Transcript Invitae Corporation 2023 Q2 - Results - Earnings Call Presentation Invitae Is Treading In Competitive Waters Invit...

Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO PR Newswire – Christine Gorjanc resumes role as Chair of the Audit Committee of the Board of Directors for Invitae – SAN FRANCISCO , Aug. 14, 2023 /PRNewswire/ -- ...

2023-08-11 08:00:00 ET Fool.com contributor Parkev Tatevosian offers investors an earnings review of Invitae (NYSE: NVTA) and lets you know if the beaten-down growth stock is a buy. *Stock prices used were the afternoon prices of Aug. 8, 2023. The video was published on Aug. 1...